七月 2026
- Home
- MOVANTIK
七月 2026的MOVANTIK市场份额分析
View the safety profile demonstrated across MOVANTIK clinical trials. Curious about side effects and adverse events?
MOVANTIK(包含公司地区分支机构)
查看更多网站流量和参与度信息- movantik.com
MOVANTIK收入截至 七月 2026为 200M - 500M
MOVANTIK主要域名产生的收入
3 年中MOVANTIK主要域名的收入
MOVANTIK主要域名的收入
MOVANTIK热门域名的总访问量
了解MOVANTIK市场份额和潜在市场覆盖范围。
过去 3 个月的总访问量
子公司明细
MOVANTIK热门域名的平均访问时长
分析MOVANTIK参与度指标。
过去 3 个月的平均访问时长
子公司明细
MOVANTIK热门域名的平均页面浏览量
了解MOVANTIK如何保持用户参与度、培养用户兴趣和鼓励采取后续操作。
过去 3 个月的平均页面浏览量
子公司明细
想要获取更深入的流量洞见?
过滤超过 2030 万家在线企业。发现流量激增的新潜在客户,开始或停止使用技术的新潜在客户,或者获得正面报道的新潜在客户。
MOVANTIK 的新闻与信号
借助 Similarweb 销售信号提醒,每当在目标受众之中出现新的机会或威胁时,您都会收到所识别出购买信号的每日更新。
新闻Movantik partners with Apollo Care, LLC..Over the last 12 months, in partnership with Apollo Care, Valinor has implemented a suite of integrated sales, analytics, patient access, and gross-to-net management solutions that have provided the basis for record prescription growth while reducing gross-to-net and operating costs.
七月 25, 2024阅读更多
新闻Grünenthal GmbH acquires Movantik for $250M.Grünenthal has announced the acquisition of US-based Valinor Pharma, along with its opioid-induced constipation (OIC) therapy Movantik, in a $250m deal which includes complete royalty obligations.
七月 23, 2024阅读更多
新闻Valinor Pharma, LLC. acquired Movantik on Jul 23rd '24.Valinor Pharma acquired Movantik in early 2023 and has leveraged Apollo Care's commercial platform to grow Movantik volume in the US while reducing gross-to-net and operating costs - Apollo Care works with pharmaceutical manufacturers to make their prescription medications affordable and accessible for patients.
七月 23, 2024阅读更多
查看 MOVANTIK 的所有信号
让您的销售团队专注于最有希望的机会。通过分清机会的轻重缓急并在合适的时机介入,您可以优化工作并达成更多交易。
